Hirooka Masashi, Koizumi Yohei, Imai Yusuke, Yukimoto Atsushi, Watanabe Takao, Yoshida Osamu, Abe Masanori, Hiasa Yoichi
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
J Med Ultrason (2001). 2018 Oct;45(4):555-564. doi: 10.1007/s10396-018-0879-9. Epub 2018 Apr 18.
The aim of this study was to clarify whether ultrasound quantitative methods were positively correlated with volume of ascites evaluated by whole abdominopelvic CT.
Sixty-eight patients with cirrhotic ascites were retrospectively analyzed. First, to confirm that virtual ultrasonography (VUS) is an alternative method to conventional ultrasound, 22 patients underwent both conventional ultrasonography and VUS. Second, the efficacy of US quantitative methods (3-point method, 4-point method, 5-point method, and Matsumoto's method) was confirmed by VUS in 68 patients. We assessed whether the ascites volume predicted by VUS corresponded with that calculated by 3D-CT. Of the 68 patients, 23 patients were analyzed before and after administration of tolvaptan.
The predictive volumes calculated by VUS were remarkably relative to those yielded by conventional US. Correlations between exact volume and those measured by VUS were significantly high (3-point method: r = 0.882, p < 0.001; 4-point method: r = 0.797, p < 0.001; 5-point method: r = 0.836, p < 0.001; Matsumoto's method: r = 0.453, p < 0.001). Correlations between decreasing volume on 3D-CT and that measured by VUS were also significantly high in patients with administration of tolvaptan.
Ascites volume measured by ultrasound was effective, especially the 3-point and 5-point methods. It was useful to assess the efficacy of diuretics in cirrhotic patients.
本研究旨在阐明超声定量方法与通过全腹盆腔CT评估的腹水量是否呈正相关。
回顾性分析68例肝硬化腹水患者。首先,为证实虚拟超声检查(VUS)是传统超声的替代方法,22例患者同时接受了传统超声检查和VUS。其次,通过VUS在68例患者中证实了超声定量方法(3分法、4分法、5分法和松本法)的有效性。我们评估了VUS预测的腹水量是否与三维CT计算的腹水量相符。在这68例患者中,23例患者在服用托伐普坦前后进行了分析。
VUS计算的预测体积与传统超声检查得到的体积显著相关。精确体积与VUS测量体积之间的相关性非常高(3分法:r = 0.882,p < 0.001;4分法:r = 0.797,p < 0.001;5分法:r = 0.836,p < 0.001;松本法:r = 0.453,p < 0.001)。在服用托伐普坦的患者中,三维CT上减少的体积与VUS测量的体积之间的相关性也非常高。
超声测量的腹水量是有效的,尤其是3分法和5分法。它有助于评估肝硬化患者利尿剂的疗效。